From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves Progenics' Azedra

from Drug Store News

The Food and Drug Administration has approved Progenics Pharmaceuticals’ Azedra (iobenguane I 131) injection for intravenous use, the company announced recently. The drug is indicated for the treatment of adults and adolescents age 12 years old and older with rare tumors of the adrenal gland — pheochromocytoma or paraganglioma — that cannot be surgically removed — unresectable — have spread beyond the original tumor site and require systemic anticancer therapy. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063